Evofem Biosciences, Inc. (EVFM)

USD 0.01

(-1.11%)

Long Term Debt Summary of Evofem Biosciences, Inc.

  • Evofem Biosciences, Inc.'s latest annual long term debt in 2023 was 8000.00 USD , down -99.74% from previous year.
  • Evofem Biosciences, Inc.'s latest quarterly long term debt in 2024 Q2 was 1000.00 USD , down 0.0% from previous quarter.
  • Evofem Biosciences, Inc. reported annual long term debt of 3.13 Million USD in 2022, down -29.18% from previous year.
  • Evofem Biosciences, Inc. reported annual long term debt of 4.42 Million USD in 2021, down -85.84% from previous year.
  • Evofem Biosciences, Inc. reported quarterly long term debt of 1000.00 USD for 2024 Q2, down 0.0% from previous quarter.
  • Evofem Biosciences, Inc. reported quarterly long term debt of 8000.00 USD for 2023 FY, down -99.74% from previous quarter.

Annual Long Term Debt Chart of Evofem Biosciences, Inc. (2023 - 2012)

Historical Annual Long Term Debt of Evofem Biosciences, Inc. (2023 - 2012)

Year Long Term Debt Long Term Debt Growth
2023 8000.00 USD -99.74%
2022 3.13 Million USD -29.18%
2021 4.42 Million USD -85.84%
2020 31.24 Million USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD -100.0%
2015 7.2 Million USD -26.03%
2014 9.74 Million USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%

Peer Long Term Debt Comparison of Evofem Biosciences, Inc.

Name Long Term Debt Long Term Debt Difference
Burzynski Research Institute, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 1.75 Million USD 99.544%
Qrons Inc. 80 Thousand USD 90.0%
Adynxx, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 20.31 Million USD 99.961%
ProtoKinetix, Incorporated - USD -Infinity%
Skye Bioscience, Inc. 171.23 Thousand USD 95.328%
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 99.962%
Intellipharmaceutics International Inc. - USD -Infinity%
Propanc Biopharma, Inc. 58.64 Thousand USD 86.358%
Mesoblast Limited 100.29 Million USD 99.992%
Marizyme, Inc. 667.12 Thousand USD 98.801%
Genus plc 228.2 Million USD 99.996%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 99.995%
Therapeutic Solutions International, Inc. 5512.00 USD -45.138%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation 2.21 Million USD 99.638%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD 99.43%
IMV Inc. 27.39 Million USD 99.971%
AXIM Biotechnologies, Inc. 5.42 Million USD 99.853%
MultiCell Technologies, Inc. 36.43 USD -21859.923%
ONE Bio Corp. 592.19 Thousand USD 98.649%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 99.986%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD 99.641%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 99.349%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 554.59 Thousand USD 98.557%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD 68.378%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 1.89 Million USD 99.579%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD 97.516%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 11.23 Billion USD 100.0%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 150 Thousand USD 94.667%
Enzolytics Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 164.2 Thousand USD 95.128%
MetaStat, Inc. - USD -Infinity%
argenx SE 15.35 Million USD 99.948%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -79.533%
Genscript Biotech Corporation 287.12 Million USD 99.997%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD 93.666%
WPD Pharmaceuticals Inc. 229.29 Thousand USD 96.511%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD 96.517%
Helix BioMedix, Inc. - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 8.26 Million USD 99.903%
BioStem Technologies, Inc. 265.63 Thousand USD 96.988%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. 1064.00 USD -651.88%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD 94.653%
Regen BioPharma, Inc. 149.61 Thousand USD 94.653%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD 94.326%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 99.898%
SYBLEU INC 300 Thousand USD 97.333%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD 97.832%
International Stem Cell Corporation 445 Thousand USD 98.202%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 99.902%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD 98.249%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD 99.311%
PureTech Health plc 18.25 Million USD 99.956%
Coeptis Therapeutics, Inc. 150 Thousand USD 94.667%
IXICO plc 275 Thousand USD 97.091%
IntelGenx Technologies Corp. 11.83 Million USD 99.932%
Gelesis Holdings, Inc. 26.3 Million USD 99.97%
CSL Limited 11.23 Billion USD 100.0%
Cellectis S.A. 36.21 Million USD 99.978%